Eli Lilly and Company: Pharma leader in diabetes and weight-loss drugs (Mounjaro, Zepbound).
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
![]() | LLYUSDT | 1,155.27 | 1,155.27 | +0.0 bps | --:--:--+0.0000%(+0.00% ann) | $738.85K | 39.0% | $2.13M | 110d |
![]() | LLYUSDT | 1,154.64 | 1,154.64 | +0.0 bps | --:--:--+0.0000%(+0.00% ann) | $405.5K | 21.4% | $1.31M | 131d |
![]() | LLY-USDT-SWAP | 1,154.40 | 1,155.26 | -7.4 bps | --:--:--+0.0000%(+0.00% ann) | $259.29K | 13.7% | $792.58K | 145d |
![]() | LLY_USDT | 1,154.11 | 1,154.12 | -0.1 bps | --:--:--+0.0000%(+0.00% ann) | $215.66K | 11.4% | $1.3M | 233d |
| LLY-USDC | 1,153.50 | 1,153.80 | -2.6 bps | --:--:--+0.0006%(+5.47% ann) | $139.19K | 7.4% | $8.65M | 184d | |
![]() | LLYSTOCK_USDT | 1,155.37 | 1,154.67 | +6.1 bps | --:--:--+0.0000%(+0.00% ann) | $80.59K | 4.3% | $5.07M | 193d |
![]() | LLYUSDT | 1,154.81 | 1,154.79 | +0.1 bps | --:--:--+0.0000%(+0.00% ann) | $53.19K | 2.8% | $2.25M | 313d |